Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or Intermedia

Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or Intermedia

Objectives: Chelating agents remain the mainstay in reducing the iron burden and extending patient survival in homozygous beta-thalassemia but adverse and toxic effects may increase with the institution and long term use of this essential therapy. This study aimed to estimate the incidence of defera...

Full description

Bibliographic Details
Main Authors: Murtadha Al-Khabori, Sunil Bhandari, Mohammed Al-Huneini, Khalil Al-Farsi, Vinodh Panjwani, Shahina Daar
Format: Article
Language:English
Published: Oman Medical Specialty Board 2013-03-01
Series:Oman Medical Journal
Subjects:
Chelator
Kidney function
Thalassemia
Toxicity.
Online Access:http://www.omjournal.org/fultext_PDF.aspx?DetailsID=355&type=fultext

Internet

http://www.omjournal.org/fultext_PDF.aspx?DetailsID=355&type=fultext

Similar Items